ArticleScientific reports2026
Attenuation of biofilm-encoding genes and virulence attributes in clinical isolates of Acinetobacter baumannii by essential oil derived from Myroxylon balsamum.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Deciphering Nano-Bio Interactions of Hyaluronic Acid-Clove Carbon Dots for Multifunctional Endodontic Nanotherapy.Dentistry journal · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Biofilm-associated infections due to recalcitrant bacterial pathogens pose a major challenge to global public health. Acinetobacter baumannii (A. baumannii) a multidrug-resistant bacterial pathogen, relies on biofilm formation and quorum sensing (QS) for sustained virulence and survival in the host. Here, we evaluated the anti-biofilm and anti-virulence potential of Myroxylon balsamum essential oil (M. balsamum EO) against A. baumannii (MCC-AB-07). M. balsamum EO disrupted biofilm formation, inhibited swarming motility, and increased bacterial susceptibility to oxidative stress. Our RT-qPCR investigations confirmed downregulation of key biofilm and QS genes. Additionally, M. balsamum EO resulted in improved survival of Caenorhabditis elegans following infection. Our findings indicate promising anti-biofilm and anti-virulence properties of M. balsamum EO, warranting elaborate investigations to explore its therapeutic applications and possible synergistic and complementary effects in conjunction with antibiotics.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.